‘We’ll look back and say that this was a bargain.’ Takeda reveals first data from its $4 billion autoimmune disease pill. – The Boston Globe March 18, 2023
What kind of PhIIb data is worth $4B cash? Takeda’s Andy Plump has some thoughts on that – Endpoints News March 17, 2023
Racial, economic disparities skew New Jersey data on autism, intellectual disability | Spectrum January 26, 2023
Moderna jumps into pivotal pack with promising RSV data as big rivals face off in megablockbuster race – Endpoints News January 18, 2023January 18, 2023